Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.
Description
In today's business landscape, the true worth of most companies lies in their innovative concepts and the effectiveness of their execution. The ability to innovate and safeguard intellectual property is vital for the longevity and success of businesses. However, a significant number of organizations continue to rely on outdated methods such as spreadsheets, file folders, banker boxes, emails, or ineffective tools for tracking their assets. This reliance leads to inefficiencies, lost resources, unrealized potential, and heightened risk. Decipher offers a subscription-based Software-as-a-Service (SaaS) solution specifically designed for managing intellectual property. It serves as a centralized, secure platform that facilitates connections among your organization’s inventors, managers, and executives, ensuring access to essential information. Decipher simplifies the process for engineers, scientists, and other contributors to submit their innovative ideas for evaluation. For instance, if a scientist in a biotech company discovers a new molecule that may lead to a treatment for a disease, they can quickly utilize our software to enter their idea and submit it. This action not only safeguards the idea as valuable knowledge but also streamlines the review process, ensuring that no valuable insights are overlooked. By opting for modern solutions like Decipher, companies can enhance their ability to innovate while minimizing risks associated with traditional tracking methods.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
Yes
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
Yes
Vendor Details
Company Name
BenevolentAI
Founded
2013
Country
Luxembourg
Website
www.benevolent.com
Vendor Details
Company Name
Decipher IP
Founded
2002
Country
United States
Website
decipherip.com
Product Features
Product Features
Intellectual Property Management
Deadline Management
No
Docket Management
No
Document Management
No
IP Portfolio Management
No
Information Disclosure Management
No
Patent Tracking
No
Renewal Management
No
Spend Management
No
Trademark Tracking
No